Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate

Product Name :
Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate

Search keywords :
Fluticasone furoate

drugId :
null

Target Vo:
Beta-2 adrenergic receptor

Target Vo Short Name :
ADRB2

Moa_Name:
Muscarinic acetylcholine receptor M1 antagonists

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :
Glaxo Operations Uk Ltd

Active Indication_Name:
Asthma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bcl2 Antibody (YA824)
HRP-conjugated AffiniPure Goat Anti-Rabbit IgG H&L
S100A10 Antibody (YA675): S100A10 Antibody (YA675) is a non-conjugated and Mouse origined monoclonal antibody about 11 kDa, targeting to S100A10 (6F4). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts